Cargando…

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk　― The Fushimi AF Registry ―

Background: The ELDERCARE-AF trial demonstrated that low-dose edoxaban prevented stroke or systemic embolism (SE) in very elderly Japanese patients with non-valvular atrial fibrillation (NVAF) in whom standard oral anticoagulant therapy was inappropriate because of high bleeding risk. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ide, Yuya, Ogawa, Hisashi, Ishigami, Kenjiro, Ikeda, Syuhei, Doi, Kosuke, Hamatani, Yasuhiro, Fujino, Akiko, An, Yoshimori, Ishii, Mitsuru, Iguchi, Moritake, Masunaga, Nobutoyo, Esato, Masahiro, Tsuji, Hikari, Wada, Hiromichi, Hasegawa, Koji, Abe, Mitsuru, Lip, Gregory Y.H., Akao, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2021
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578123/ https://www.ncbi.nlm.nih.gov/pubmed/34805602 http://dx.doi.org/10.1253/circrep.CR-21-0121

Ejemplares similares

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
por: Esato, Masahiro, et al.
Publicado: (2022)

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
por: Hamatani, Yasuhiro, et al.
Publicado: (2015)

Spontaneous coronary artery dissection in a woman undergoing pseudomenopause therapy with leuprorelin: A case report
por: Doi, Kosuke, et al.
Publicado: (2019)

Isometric Handgrip Stress Test during Right Heart Catheterization in Patients with Mitral Regurgitation -A Case Series Study-
por: Hamatani, Yasuhiro, et al.
Publicado: (2021)

Utility of left ventricular ejection fraction in atrial fibrillation patients without pre‐existing heart failure
por: Hamatani, Yasuhiro, et al.
Publicado: (2023)

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
por: Ogawa, Hisashi, et al.
Publicado: (2017)

Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
por: Kawaji, Tetsuma, et al.
Publicado: (2022)

Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
por: Kobayashi, Kosuke, et al.
Publicado: (2022)

Machine Learning Risk Prediction for Incident Heart Failure in Patients With Atrial Fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2022)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
por: Yasuda, Ken, et al.
Publicado: (2018)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant
por: Aono, Yuya, et al.
Publicado: (2020)

Differential response to isometric handgrip depending on the heart failure condition in patients with functional mitral regurgitation: a case report
por: Hamatani, Yasuhiro, et al.
Publicado: (2022)

Utility of handgrip stress test in patients with functional mitral regurgitation and exertional dyspnoea
por: Hamatani, Yasuhiro, et al.
Publicado: (2020)

Acquired Factor V Inhibitor
por: Hirai, Daisuke, et al.
Publicado: (2016)

Local abnormal atrial activity related to right septal intra-atrial reentrant tachycardia after mitral valve surgery
por: An, Yoshimori, et al.
Publicado: (2021)

Correction to: Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
Publicado: (2022)

VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2018)

Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry
por: Iguchi, Moritake, et al.
Publicado: (2021)

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020)

Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020)

Clinical significance of ST-segment depression during atrial fibrillation rhythm for subsequent heart failure events
por: Kawaji, Tetsuma, et al.
Publicado: (2023)

Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients
por: Hamatani, Yasuhiro, et al.
Publicado: (2022)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Guo, Yutao, et al.
Publicado: (2020)

Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach
por: Kozieł-Siołkowska, Monika, et al.
Publicado: (2022)

A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J‐ELD AF Registry)
por: Okumura, Ken, et al.
Publicado: (2019)

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023)

Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE–AF Randomized Clinical Trial
por: Kuroda, Masaru, et al.
Publicado: (2022)

Impact of anemia on the clinical outcomes in elderly patients with atrial fibrillation receiving apixaban: J-ELD AF registry subanalysis
por: Tanaka, Nobuaki, et al.
Publicado: (2022)

Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis
por: Okada, Masato, et al.
Publicado: (2021)

Photothermal Agarose Microfabrication Technology for Collective Cell Migration Analysis
por: Sentoku, Mitsuru, et al.
Publicado: (2021)

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
por: Kotecha, Dipak, et al.
Publicado: (2017)

Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program
por: McIntyre, William F., et al.
Publicado: (2018)

Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry
por: Bucci, Tommaso, et al.
Publicado: (2023)

Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure
por: Iguchi, Moritake, et al.
Publicado: (2021)

Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial
por: Akashi, Shintaro, et al.
Publicado: (2022)

Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2019)

Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial
por: Yoshida, Tetsuro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtb0l8djo2tlcnii1qafe4kbp5